Login / Signup
Phil Jeffrey
ORCID
Publication Activity (10 Years)
Years Active: 2022-2023
Publications (10 Years): 2
Top Topics
Open Label
Cancer Therapy
Molecularly Imprinted
Tandem Mass Spectrometry
Top Venues
Bioanalysis
Molecular cancer therapeutics
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Joseph A Tweed
,
Fern Adams-Dam
,
Jane Allanson
,
Kevin Holmes
,
Ryan Senior
,
Hongmei Xu
,
Mengyao Li
,
Gavin Bennett
,
Phil Jeffrey
Bioanalysis of the Bicycle ® toxin conjugate BT5528 and released monomethyl auristatin E via liquid chromatography-tandem mass spectrometry.
Bioanalysis
(2023)
Michael Rigby
,
Gavin Bennett
,
Liuhong Chen
,
Gemma E Mudd
,
Helen Harrison
,
Paul J Beswick
,
Katerine van Rietschoten
,
Sophie M Watcham
,
Heather S Scott
,
Amy N Brown
,
Peter U Park
,
Carly Campbell
,
Eric Haines
,
Johanna Lahdenranta
,
Michael J Skynner
,
Phil Jeffrey
,
Nicholas Keen
,
Kevin Lee
BT8009; A Nectin-4 Targeting Bicycle Toxin Conjugate for Treatment of Solid Tumors.
Molecular cancer therapeutics
21 (12) (2022)